Login / Signup

Efficacy and Safety of Upacicalcet in Hemodialysis Patients with Secondary Hyperparathyroidism: A Randomized Placebo-Controlled Trial.

Takashi ShigematsuFumihiko KoiwaYoshitaka IsakaMasafumi FukagawaKeiko HagitaYukihisa S WatanabeDaisuke HondaTadao Akizawa
Published in: Clinical journal of the American Society of Nephrology : CJASN (2023)
Phase 3 Study of SK-1403, NCT03801980.
Keyphrases
  • double blind
  • placebo controlled
  • end stage renal disease
  • peritoneal dialysis
  • open label
  • chronic kidney disease
  • clinical trial
  • study protocol